Navigation Links
Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
Date:5/6/2008

ARLINGTON, Va., May 6 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, announced today the completion of a Service Agreement with Concordia Pharmaceuticals, Inc. and initiation of preclinical studies to evaluate new applications for Salirasib using Champions Biotechnology's Biomerk Tumorgrafts(TM).

"Our Biomerk Tumorgraft preclinical platform and its benefits in drug discovery and evaluation is gaining recognition as we expand our platform to pharmaceutical and biotech companies" said Doug Burkett, Ph.D., President of Champions Biotechnology, Inc. "Champions is in a unique position to evaluate oncology drugs as well as novel drug combinations that may be effective in treating specific cancer types. We are pleased to be assisting Concordia Pharmaceuticals in the evaluation of new preclinical applications for Salirasib, a Ras-antagonist that acts to inhibit cancer by impairing the disease's ability to replicate defective cells."

For more information regarding Champions Biotechnology's growing business and recent news, please visit http://www.championsbiotechnology.com.

About Champions Biotechnology, Inc.

Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs. The Company's Preclinical Platform is a novel approach based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting xenografts (Biomerk Tumorgrafts(TM)) in a manner that preserves the biological characteristics of the original human tumor. The Company believes that these Tumorgrafts closely reflect human cancer biology and their response to drugs is more predictive
'/>"/>

SOURCE Champions Biotechnology
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...CAGO, Nov. 29 Royal Philips Electr...e to an industry need by showing its portfolio of ... year,s 95th annual meeting of the Radiological So...s year from Philips are several advancements and u...se radiation and streamlining workflow to expand u...
(Date:11/29/2009)..., Nov. 29 FUJIFILM Medical Systems...s revolutionary flat panel DR cassette, at the 200...ual Meeting. Ideal for any clinical environment, ...vide clinicians with Fujifilm,s trademark image qu...s a smart way for users to transition to DR withou...
(Date:11/29/2009)..., Nov. 29 Stimulated by the ten ye...jifilm Medical Systems USA announced today, at the...al meeting, the formation of its Medical Informat..., this new group will integrate all functions asso... creates a platform for future growth. ,, Sever...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Report Gives U S Good Grades for Swine Flu Response 47988 1Report Gives U S Good Grades for Swine Flu Response 47988 2Report Gives U S Good Grades for Swine Flu Response 47988 3Report Gives U S Good Grades for Swine Flu Response 47988 4Patrick Johnston Named President and CEO of the California Association of Health Plans 47986 1Patrick Johnston Named President and CEO of the California Association of Health Plans 47986 2Pennsylvania Department of Health Launches Spanish Language Smoking Cessation Resource Web Site 47984 1Pennsylvania Department of Health Launches Spanish Language Smoking Cessation Resource Web Site 47984 2
...g a,thorough review that concluded late yesterday,... PGL; Nasdaq: PGLA) today announced that it,had di.... Progen confirmed,its strategic direction to deve...mpany will actively seek to acquire additional com...ion activity., The strategic review was triggered...
...opment Initiative bring MJFF,s,current active indu...0,2009, NEW YORK, July 22 As part of its mission...d a cure for Parkinson,s,disease, The Michael J. F...,$2.7 million in total funding to six industry res...Therapeutics Development Initiative (TDI),program....
Other Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3
(Date:11/29/2009)...ATLANTA, Nov. 29 The following is ...t Securities Research, Inc. ,, Intellivest Secu...d investment advisor, has published a Report on Bi...he pharmaceutical, biotechnology and medical devic...clients manage, process and submit medical imaging...
(Date:11/29/2009)...Z, CA--New connections begin to form between brain...ask, according to a study published this week in ...alifornia, Santa Cruz, the study involved detailed...place in the brain during motor learning. , The ...each through a slot to get a seed. They observed r...
(Date:11/29/2009)...g, a $1,300 round of treatment equals a $41,000 pa...ov. 28 (HealthDay News) -- Psychological therapy m...han getting a raise or winning a lottery prize, su... data on thousands of people who provided informat...he increase in happiness from a $1,329 course of t...
(Date:11/29/2009)... Traditional healthcare,s uncertain fu...ordable alternative care. Affordable Acupuncture S... (PRWEB) November 29, 2009 -- Affordable Acupu...ear (2009) and has been met with enthusiasm and gr...ss can be attributed to two things, need and cost....
(Date:11/28/2009)...ers were more likely to consider change after 30-m... , FRIDAY, Nov. 27 (HealthDay News) -- A pro...r why they should stop their dangerous behavior ma...searchers have found. , The new study included ...mpaired convictions, who were randomly assigned to...
Breaking Medicine News(10 mins):Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2
...LE, Md., Feb. 27 Novavax, Inc.,(Nasdaq: NVAX ) a...hat Dr.,Rahul Singhvi, President and Chief Executi...s Second Annual SIGnificant Options in Healthcare,...elopment progress. A link to the live presentation...
...K, Feb. 27, 2008 Reflecting the,Company,s positiv...live,Company today increased the ongoing quarterly...ill be effective as of second quarter 2008. The ne...of record as of April 24, 2008. On an annualized b...
... BEACH, Calif., Feb. 27 Nationwide,Health Propert...d Chief,Executive Officer, Douglas M. Pasquale and...oury will make a brief presentation at the Citigro... presentation can be heard live via teleconference...
...r the surgical removal of a malignant tumor, the c...cation of the body remains high. But new research ...ed Psychoneuroimmunology, may prevent those cancer...sitys Department of Psychology, has shown scientif...
...ting insulin doses to lose weight increases chance...DAY, Feb. 27 (HealthDay News) -- Women with type 1...o try to lose weight triple their risk of dying co...bbri, lead author of a study in the March issue of...
...udy by the University of Minnesota School of Publi...at tweens should receive alcohol prevention progra...ildren are already alcohol users., The study foun...between third and fifth grade, would allow for tru...
Other Medicine News:Health News:Nationwide to Present at Citigroup Global Property CEO Conference 2Health News:Nationwide to Present at Citigroup Global Property CEO Conference 3Health News:Stress and fear can affect cancer's recurrence 2Health News:Stress and fear can affect cancer's recurrence 3Health News:'Diabulimia' Triples Risk of Death Among Women With Diabetes 2Health News:U of Minn researchers find primary alcohol prevention programs are needed for 'tweens' 2
...novative design of the PARAHISIAN catheter, combin... spaced electrodes, which permits the use of only ...d recording of His bundle electrograms. The "two c...ement through a single venipuncture. The disadvant...
Webster Quadrapolar Standard Deflectable Catheters
Explorer 360 Jr.
...se Webster offers a wide range of deflectable curv...ial needs of children and other patients with smal...ding specifications using only the finest material...roven wire braiding and extrusion technologies res...
Medicine Products: